

Supported
by

Dr. David Tan
National University Cancer Institute, National University of Singapore, Singapore

Dr Tan is a senior consultant medical oncologist at the National University Cancer Institute, Singapore and an Associate Professor in the Department of Medicine at the Yong Loo Lin School of Medicine, National University of Singapore and Principal Investigator at the Cancer Science Institute, National University of Singapore. He graduated from Guy’s, King’s and St Thomas’ School of Medicine in London, UK and trained in internal medicine at Hammersmith and Guy’s and St Thomas’ Hospitals. He obtained his PhD in Oncology at the Institute of Cancer research in London and trained in Medical Oncology at the Royal Marsden Hospital in London and Princess Margaret Cancer Centre in Toronto, Canada. His primary clinical and research interests are in gynaecological cancers, precision oncology, and early phase trials. He has authored over 100 peer-reviewed scientific papers and received several awards for his research. Dr Tan is currently the Head of the Innovation Transfer Office at National University Health Systems (NUHS). He was the founding President of the Gynecologic Cancer Group Singapore (GCGS), and past-chairman of the Asia-Pacific Gynaecologic Oncology Trials (APGOT) Group. He currently also chairs the Cervical Cancer Research Network (CCRN) and is a member of the executive board of directors of the Gynecologic Cancer InterGroup (GCIG).